# HE 2 - Basic Economic Tools

**MQB7014: Health Economics**  
**Master of Public Health (MPH) Programme, University of Malaya**  
**Prepared by: Dr. Nithiah Thangiah**  
**Acknowledgement: Prof. Ng Chiu Wan, Dept. of Social and Preventive Medicine, Faculty of Medicine, University of Malaya**  

---

## ðŸ“ Executive Summary

The lecture **HE 2 - Basic Economic Tools** provides a comprehensive foundation in economic principles applied to healthcare, equipping students with tools to analyze resource allocation, pricing, and market dynamics in **Health Economics**. Covering **utility measurement**, **supply and demand**, **elasticity**, **market structures**, and **equilibrium**, the lecture blends theoretical frameworks with practical healthcare applications, supported by empirical studies like the **Rand Health Insurance Experiments** and **Madagascar fee exemption study**. Below, we summarize the **key concepts**, **terminologies**, **major findings**, and **implications** for healthcare policy, highlighting how these tools inform equitable and efficient healthcare systems.

### ðŸŽ¯ Overview of the Lecture

**HE 2** introduces fundamental economic tools to analyze healthcare markets, emphasizing their role in understanding **resource scarcity**, **consumer behavior**, and **provider incentives**. The lecture explores how **prices**, **non-price factors**, and **market structures** shape healthcare access and delivery, using real-world examples to illustrate applications. Key objectives include understanding **supply and demand dynamics**, exploring **utility** and **elasticity**, examining **perfect competition**, and applying these principles to healthcare via empirical evidence.

- **Purpose**: Equip students with economic tools to analyze healthcare resource allocation and inform policy.
- **Scope**: Covers **utility**, **demand**, **supply**, **elasticity**, **market structures**, and **equilibrium**, with healthcare applications.
- **Relevance**: Provides a framework for addressing challenges like high drug prices, hospital shortages, and equitable access.

### ðŸ“š Key Concepts and Terminologies

The lecture introduces critical economic concepts and terminologies, each with specific applications in healthcare. Below is a summary of the **key terminologies** and their significance.

| **Terminology**                      | **Definition**                                                                                                                                 | **Healthcare Application**                                                                                               |
| ------------------------------------ | ---------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------ |
| **Utility**                          | Satisfaction or value from consuming a good/service, proxied by price paid.                                                                    | Measures patient value for treatments (e.g., willingness to pay for a vaccine).                                          |
| **Diamond-Water Paradox**            | Discrepancy between **total utility** (overall value) and **marginal utility** (additional value), explaining why scarce goods are pricier.    | Explains low prices for essential drugs (high total utility) vs. high prices for rare therapies (high marginal utility). |
| **Demand**                           | Amount of a good/service customers are willing and able to buy over time.                                                                      | Patients seeking consultations or medications based on price and income.                                                 |
| **Law of Demand**                    | When price falls, quantity demanded rises (inverse relationship).                                                                              | Lower co-pays increase clinic visits.                                                                                    |
| **Demand Function**                  | Relationship between quantity demanded and factors: $Q_d = f(P, RP, Y, T, \ldots)$.                                                            | Models patient demand influenced by price ($P$), related goods ($RP$), income ($Y$), and preferences ($T$).              |
| **Supply**                           | Amount of a good/service sellers are willing and able to sell over time.                                                                       | Hospitals offering surgeries based on fees and costs.                                                                    |
| **Law of Supply**                    | When price rises, quantity supplied rises (direct relationship).                                                                               | Higher reimbursement rates increase vaccine production.                                                                  |
| **Supply Function**                  | Relationship between quantity supplied and factors: $Q_s = f(P, RP, C, T, \ldots)$.                                                            | Models provider supply based on price ($P$), related goods ($RP$), costs ($C$), and technology ($T$).                    |
| **Price Elasticity of Demand (PED)** | Responsiveness of quantity demanded to price changes: $\text{PED} = \frac{\% \text{ change in } Q_d}{\% \text{ change in } P}$.                | Assesses how co-pay increases affect clinic attendance (e.g., PED = -0.79 in Burkina Faso).                              |
| **Cross Elasticity of Demand (CED)** | Change in demand for one good due to price change of another: $\text{CED}_{AB} = \frac{\% \text{ change in } Q_A}{\% \text{ change in } P_B}$. | Measures substitution between public and private clinics (e.g., CED = +0.15 in Malaysia).                                |
| **Market**                           | All buyers and sellers of a good/service, balancing supply and demand.                                                                         | Patients and hospitals in the market for surgical services.                                                              |
| **Perfect Competition**              | Market with many firms, identical products, free entry/exit, and perfect information, maximizing efficiency.                                   | Generic drug markets, where competition lowers prices.                                                                   |
| **Equilibrium**                      | Price where quantity supplied equals quantity demanded: $Q_d = Q_s$.                                                                           | Consultation fees balancing patient demand and clinic supply, avoiding shortages/surpluses.                              |
| **Rational Decision-Making**         | Maximizing **utility** within constraints, balancing costs and benefits.                                                                       | Patients choosing affordable treatments; providers assessing equipment investments.                                      |
| **Marginal Analysis**                | Focus on **incremental costs and benefits** for decision-making.                                                                               | Evaluating whether a new drugâ€™s benefits justify its additional cost in healthcare budgets.                              |

### ðŸ” Major Findings and Insights

The lecture draws on empirical studies and theoretical examples to illustrate how economic tools apply to healthcare, revealing key findings with practical implications.

- **Utility and Pricing**:
  - The **diamond-water paradox** shows prices reflect **marginal utility** and **scarcity**, not just **total utility**. Essential healthcare services (e.g., antibiotics) are often cheap due to abundance, while rare treatments (e.g., gene therapies) are costly due to high marginal utility.
  - **Utility** is proxied by price, helping policymakers understand patient valuation of care.

- **Demand Dynamics**:
  - The **law of demand** is evident in healthcare: lower prices increase utilization. The **Madagascar fee exemption study (2017)** showed a **65% increase** in overall healthcare use, **52% for children under five**, and **>25% for maternity consultations when fees** were removed, costing only **US$0.60 per patient**.
  - The **Rand Health Insurance Experiments (1971â€“1982)** found **cost-sharing reduced utilization** (e.g., 86.7% likelihood of use with free care vs. 68.0% with 95% cost-sharing) without significantly affecting **quality of care** or **health outcomes**, except in vulnerable groups.

- **Supply Dynamics**:
  - The **law of supply** drives provider behavior: higher prices increase supply. For example, higher reimbursement rates incentivize hospitals to offer more procedures.
  - Non-price factors, like lower production costs or technological advances, shift the **supply curve** right, increasing availability (e.g., cheaper vaccine ingredients boost supply).

- **Elasticity**:
  - **PED** varies by service and population. In Burkina Faso, overall PED is **-0.79** (inelastic), but infants (PED = **-3.64**) and low-income groups (PED = **-1.44**) are highly elastic, showing vulnerability to price changes.
  - **CED** reveals substitution effects. In Malaysia (1975), a **+0.15 CED** for public vs. private clinics indicates patients switch to public care when private fees rise, while a **+0.05 CED** shows limited substitution to traditional care when western care costs increase.
  - **Inelastic demand** (PED < 1) doesnâ€™t mean price increases are harmless. In Burkina Faso, a US$0.57 user fee reduced care-seeking by **26% for infants** and **10.4% for the poorest**, exacerbating **underuse** (0.31 contacts/year), **inequity**, and **health risks** (e.g., missed immunizations).

- **Market Structures**:
  - **Perfect competition** maximizes efficiency, with many firms, identical products, free entry/exit, and perfect information. Though rare in healthcare, it serves as a benchmark (e.g., generic drug markets approximate this, keeping prices low).
  - Other structures like **monopolies** (e.g., patented drugs) or **oligopolies** (e.g., hospital chains) often lead to higher prices, requiring regulation.

- **Equilibrium**:
  - **Equilibrium** ($Q_d = Q_s$) ensures no shortages or surpluses. In the ice cream cone example, RM 2.00 balances 300 cones demanded and supplied, while RM 1.50 causes a **shortage** (200 cones) and RM 2.50 a **surplus** (200 cones).
  - Shifts in **supply** (e.g., cheaper raw materials) lower prices and increase quantities, while **demand** shifts (e.g., higher income) raise both, guiding healthcare resource planning.

- **Rational Decision-Making**:
  - Individuals maximize **utility** within constraints, balancing **costs** (including **opportunity costs**) and **benefits**.
  - **Marginal analysis** evaluates **incremental costs and benefits**, foundational for healthcare evaluations (e.g., cost-effectiveness of new treatments).

### ðŸš€ Implications for Healthcare Policy

The lectureâ€™s insights offer actionable guidance for healthcare policy, emphasizing **equity**, **efficiency**, and **access**:

- **Subsidies and Fee Exemptions**: The Madagascar study shows removing user fees boosts utilization, supporting **universal health coverage**. Subsidies for essentials (e.g., vaccines) maintain access, especially for vulnerable groups with high PED (e.g., infants in Burkina Faso).
- **Pricing Strategies**: **PED** and **CED** inform pricing. Inelastic demand for essential care (e.g., PED = -0.25 for outpatient services in Ghana) suggests price increases harm access without curbing frivolous use, while elastic demand for private care (e.g., PED = -1.94 in Kenya) allows fees to control demand.
- **Promote Competition**: Encouraging **perfect competition** (e.g., more generic drug producers) lowers prices and aligns services with patient needs, countering monopolistic pricing (e.g., patented drugs).
- **Address Inequities**: High PED for low-income groups and children (e.g., -1.44 and -3.64 in Burkina Faso) highlights the need for targeted exemptions to prevent **underuse** and **negative externalities** like missed immunizations.
- **Stabilize Markets**: **Equilibrium** analysis prevents shortages (e.g., insufficient hospital beds) or surpluses (e.g., excess drug stockpiles) by adjusting prices or supply incentives (e.g., subsidies for production).
- **Cost-Effectiveness**: **Marginal analysis** ensures healthcare investments (e.g., new equipment) yield sufficient benefits, optimizing resource allocation.

### ðŸ“Š Key Takeaways Table

| **Concept**                | **Key Insight**                                                                 | **Policy Implication**                                      |
|----------------------------|--------------------------------------------------------------------------------|-------------------------------------------------------------|
| Utility                    | Prices reflect **marginal utility** and scarcity, not just **total utility**.   | Subsidize essentials to ensure affordability.               |
| Demand/Supply              | Driven by price and non-price factors, visualized via curves/functions.         | Use subsidies to boost supply, campaigns to raise demand.   |
| Elasticity                 | PED/CED measure responsiveness, revealing vulnerability in low-income groups.   | Avoid fees for children/poor; promote substitutes (e.g., generics). |
| Perfect Competition        | Ideal for efficiency, benchmark for healthcare markets.                        | Encourage competition (e.g., telehealth, generics).         |
| Equilibrium                | Balances supply/demand, preventing shortages/surpluses.                        | Adjust prices/subsidies to maintain stable access.          |
| Rational Decision-Making   | Maximizes utility via **marginal analysis**.                                   | Use cost-effectiveness studies for resource allocation.     |

### ðŸŒŸ Conclusion

**HE 2 - Basic Economic Tools** equips students with a robust framework to analyze healthcare markets through **utility**, **supply/demand**, **elasticity**, **market structures**, and **equilibrium**. Key terminologies like **PED**, **CED**, **perfect competition**, and **marginal analysis** provide tools to predict behavior, assess policies, and address challenges like **underuse**, **inequity**, and **inefficiency**. Empirical evidence from studies in **Madagascar**, **the USA**, and **Malaysia** underscores the practical relevance of these concepts, guiding policies that enhance **universal health coverage**, optimize resources, and ensure equitable access. By applying these principles, policymakers can create healthcare systems that are both efficient and just, meeting the needs of diverse populations.

---

## ðŸ“š 1. Introduction to Basic Economic Tools

**Health Economics** leverages **fundamental economic tools** to dissect how resources are allocated within healthcare systems, providing insights critical for shaping effective policies. This lecture introduces core concepts that form the backbone of economic analysis in healthcare, focusing on **utility measurement**, **supply and demand dynamics**, **price and cross elasticities**, and **market structures**, with a special emphasis on **perfectly competitive markets**. These tools are not just theoretical constructsâ€”they are **essential** for understanding the complexities of healthcare markets and guiding **evidence-based policy decisions** that impact access, affordability, and efficiency.

### ðŸŒŸ Why Study Basic Economic Tools in Health Economics?

In healthcare, resources like hospital beds, medical professionals, and funding are scarce, yet the demand for quality care is immense. **Health Economics** bridges this gap by applying economic principles to optimize resource use. By mastering these tools, we can:
- **Analyze** how price changes affect healthcare utilization (e.g., doctor visits or medication purchases).
- **Evaluate** market structures to ensure fair access and competition.
- **Inform** policies that balance cost, quality, and equity, such as subsidies or universal health coverage initiatives.

The concepts covered in this sectionâ€”**utility**, **supply and demand**, **elasticities**, and **market structures**â€”provide a **framework** to tackle real-world challenges, from rising healthcare costs to disparities in access.

### ðŸŽ¯ Lecture Objectives

The lecture is designed to equip you with a robust understanding of economic principles and their application to healthcare. Here are the **key objectives**:

- **Understand**: Grasp the **dynamics of supply and demand** in markets, exploring how prices and other factors influence the behavior of consumers and producers in healthcare settings.
- **Explore**: Dive into the concept of **utility** and its measurement, including the thought-provoking **diamond-water paradox**, which reveals why some goods are priced higher despite lower practical value.
- **Analyze**: Investigate **price elasticity** and **cross elasticity** in healthcare contexts, understanding how sensitive demand is to price changes and how related goods interact.
- **Examine**: Study **market structures**, particularly the **perfectly competitive market**, and their role in achieving **economic efficiency** in resource allocation.
- **Apply**: Connect these economic principles to real-world healthcare scenarios, drawing on **empirical studies** like the **Rand Health Insurance Experiments** (1971â€“1982) and the **Madagascar fee exemptions study** (2017) to illustrate their practical relevance.

| **Objective** | **Focus Area** | **Example Application** |
|---------------|----------------|------------------------|
| Understand | Supply and Demand | How hospital bed availability responds to patient demand. |
| Explore | Utility & Diamond-Water Paradox | Why life-saving drugs are cheaper than luxury treatments. |
| Analyze | Price & Cross Elasticity | Impact of co-pays on clinic visits or demand for generics vs. branded drugs. |
| Examine | Market Structures | Efficiency of generic drug markets under competition. |
| Apply | Empirical Studies | Lessons from fee exemptions for universal health coverage. |

### ðŸš€ Relevance to Healthcare Policy

These tools are not just academicâ€”they are **actionable**. For instance:
- **Utility measurement** helps us understand patient preferences, guiding resource allocation (e.g., prioritizing essential vs. elective procedures).
- **Supply and demand dynamics** reveal how provider shortages or patient influxes affect wait times and costs.
- **Elasticities** inform pricing strategies, such as whether increasing co-pays will deter necessary care.
- **Market structures** like perfect competition highlight ways to reduce monopolistic pricing in pharmaceutical markets.

By the end of this lecture, youâ€™ll be equipped to **think like an economist**, applying these tools to analyze healthcare markets and advocate for policies that enhance **access**, **equity**, and **efficiency**.

---

## ðŸ§  2. Measuring Utility

**Utility** is a cornerstone concept in economics, capturing the essence of why people make choices in healthcare and beyond. In **Health Economics**, understanding utility helps us analyze how individuals value medical services, medications, or preventive care, guiding resource allocation and policy design. This section explores **what utility is**, the **challenges in measuring it**, and the fascinating **diamond-water paradox**, which reveals why prices donâ€™t always align with practical value. By delving into these ideas, weâ€™ll uncover how utility shapes consumer behavior and informs healthcare decisions.

### ðŸ“ What is Utility?

**Utility represents the satisfaction, advantage, or value a person derives from consuming a good or service.** Itâ€™s the **subjective benefit** someone experiencesâ€”whether itâ€™s the relief from taking a painkiller, the reassurance of a doctorâ€™s visit, or the joy of eating an ice cream cone. In **Health Economics**, utility is critical for understanding why patients choose certain treatments or prioritize specific health services.

- **Definition**: *Utility represents the satisfaction, advantage, or value a person derives from consuming a good or service.* This could be the comfort of a hospital stay or the life-saving impact of a vaccine.
- **Measurement Challenge**:
  - **No standardized unit exists** for utility. Economists use the hypothetical concept of **â€œUtilsâ€**, but itâ€™s not a tangible, measurable unit like kilograms or liters.
  - **Money** serves as a **proxy** for utility. *The price we pay for a good or service reflects the amount of satisfaction (utility) obtained.* For example, paying RM 50 for a doctorâ€™s consultation suggests the patient values the visit at least that much.
- **Key Insight**: *The price we pay for a good or service reflects the amount of satisfaction or value we obtain from consuming that good or service.* In healthcare, this means the cost of a treatment (e.g., RM 100 for medication) approximates the **value** patients place on the health benefits it provides.

#### ðŸŒ Utility in Healthcare Context

Utility helps explain patient behavior:
- A patient might pay a high price for a rare cancer drug because it offers **significant utility** (e.g., extended life expectancy).
- Conversely, a free vaccination might be highly valued for its **preventive utility**, even if no direct cost is incurred.
By using money as a proxy, policymakers can assess how much individuals value different health interventions, informing decisions like subsidizing essential drugs or prioritizing public health campaigns.

### ðŸ’Ž The Diamond-Water Paradox

The **diamond-water paradox** is a classic economic puzzle that illustrates why prices donâ€™t always reflect practical importance. It highlights the discrepancy between **total utility** (overall value) and **marginal utility** (additional value from one more unit), offering profound insights for healthcare pricing and resource allocation.

- **Concept**: *The diamond-water paradox highlights the discrepancy between **total utility** and **marginal utility**.* It asks: Why is water, essential for survival, so cheap, while diamonds, which are non-essential, are so expensive?
  - **Water**:
    - **High total utility** due to its **essential role in survival**. Without water, life is impossible, making its overall value immense.
    - **Low marginal utility and price** because water is **abundant** in most contexts. The additional value of one more liter is minimal when water is readily available.
  - **Diamonds**:
    - **Lower total utility** as they are **non-essential**. Diamonds serve decorative or status purposes, not survival.
    - **High marginal utility and price** due to **scarcity**. The rarity of diamonds makes each additional unit highly valuable, driving up prices.
- **Implication**: *Prices are driven by **scarcity** and **marginal utility**, not just total utility.* This explains why non-essential goods can command higher prices than essential ones if they are scarce.

#### ðŸ©º Applying the Paradox to Healthcare

The diamond-water paradox has direct relevance to healthcare:
- **Essential Services (like Water)**: Basic treatments like antibiotics or vaccinations have **high total utility** because they save lives or prevent disease. However, their **marginal utility** and price may be low if they are widely available (e.g., generic drugs).
- **Specialized Treatments (like Diamonds)**: Rare procedures, like experimental cancer therapies, have **lower total utility** (fewer people need them) but **high marginal utility** and price due to their scarcity and specialized nature.
- **Policy Insight**: Policymakers must ensure **essential services** remain affordable despite low marginal utility, while managing access to **scarce, high-cost treatments** to balance equity and efficiency.

| **Good**   | **Total Utility** | **Marginal Utility** | **Price** | **Reason**                     |
|------------|-------------------|----------------------|-----------|--------------------------------|
| Water      | High (Essential)  | Low (Abundant)       | Low       | High supply reduces value of additional units. |
| Diamonds   | Low (Non-essential) | High (Scarce)      | High      | Rarity increases value of each unit. |
| Antibiotics | High (Life-saving) | Low (Generic, widely available) | Low | High availability lowers cost. |
| Experimental Therapy | Lower (Niche use) | High (Rare, specialized) | High | Limited supply drives up cost. |

### ðŸš€ Why This Matters

Understanding utility and the diamond-water paradox equips us to:
- **Evaluate Patient Choices**: Why do patients prioritize certain treatments? The answer lies in the **utility** they perceive, often reflected in their willingness to pay.
- **Design Pricing Policies**: Subsidies for **high total utility** services (e.g., vaccinations) ensure access, while high prices for **scarce treatments** may require regulation to prevent inequity.
- **Optimize Resources**: By focusing on **marginal utility**, we can allocate healthcare resources where they add the most value, balancing cost and impact.

---

## ðŸ“ˆ 3. Dynamics of Demand

**Demand** is a fundamental concept in **Health Economics**, revealing how consumers make choices about healthcare services, from doctor visits to medications. This section explores the **dynamics of demand** from the **customerâ€™s perspective**, delving into its definition, determinants, and the **law of demand**. Weâ€™ll examine a practical example with a **demand schedule for ice cream cones**, introduce the **demand function**, and distinguish between **movements** and **shifts** in demand. Finally, weâ€™ll connect these concepts to healthcare through **empirical evidence** from the **Rand Health Insurance Experiments** and the **Madagascar fee exemption study**, showcasing how demand principles shape healthcare access and policy.

### ðŸ›’ Understanding Demand

**Demand is the amount of a product (good or service) that customers are willing and able to buy over a period of time.** In healthcare, this could mean the number of patients seeking consultations, vaccinations, or surgeries. Understanding demand is crucial for predicting how changes in prices or other factors affect healthcare utilization.

- **Perspective**: *From the **customerâ€™s viewpoint**.* Demand reflects the preferences and purchasing power of individuals, such as patients deciding whether to visit a clinic or purchase a prescription.
- **Definition**: *Demand is the amount of a product (good or service) that customers are willing and able to buy over a period of time.* The term â€œproductâ€ encompasses both **goods** (e.g., medicines) and **services** (e.g., hospital stays).
- **Key Determinants**:
  - **Price** of the product: The **primary factor** influencing demand. Higher prices typically reduce demand, while lower prices increase it.
  - **Non-price factors**:
    - **Income**: Higher income increases the ability to purchase healthcare services.
    - **Prices of related goods**: Includes **substitutes** (e.g., generic vs. branded drugs) and **complements** (e.g., diagnostic tests paired with treatments).
    - **Consumer preferences and tastes**: For example, a growing preference for preventive care can boost demand for screenings.

#### ðŸŒ Demand in Healthcare

In healthcare, demand reflects patientsâ€™ willingness to seek care, influenced by costs, income, and preferences. For instance, a patient might forgo a costly specialist visit if their income is low, but demand for essential services like emergency care often persists regardless of price due to necessity.

### âš–ï¸ Law of Demand

The **law of demand** is a cornerstone of economic theory, describing the inverse relationship between price and quantity demanded. It helps explain why price changes in healthcare, such as co-pays or medication costs, directly impact patient behavior.

- **Statement**: *Other things being equal, when the price of a product rises, the quantity demanded falls, and when the price falls, the quantity demanded rises.* This principle holds true in healthcare, where higher costs deter utilization, and lower costs encourage it.
- **Intuition**: *Higher prices reduce affordability, decreasing demand, while lower prices increase purchasing power, boosting demand.* For example, raising the cost of a clinic visit from RM 10 to RM 20 might lead fewer patients to seek care, while reducing it to RM 5 could increase visits.

### ðŸ¦ Demand Schedule for Ice Cream Cones

To illustrate the **law of demand**, consider a **demand schedule for ice cream cones**, which shows how quantity demanded changes with price. This example provides a clear, relatable way to visualize demand principles before applying them to healthcare.

| **Price per Cone (RM)** | **Quantity Demanded** |
|-------------------------|-----------------------|
| 0.00                    | 120                   |
| 0.50                    | 100                   |
| 1.00                    | 80                    |
| 1.50                    | 60                    |
| 2.00                    | 40                    |
| 2.50                    | 20                    |
| 3.00                    | 0                     |

- **Observation**: *As price increases, quantity demanded decreases, reflecting the **law of demand**.* At RM 0.00, 120 cones are demanded, but at RM 3.00, demand drops to zero, showing consumersâ€™ sensitivity to price.
- **Graphical Representation**: *The **demand curve** slopes **downward** from left to right, showing an inverse price-quantity relationship.* Plotting the schedule on a graph (price on the y-axis, quantity on the x-axis) produces a downward-sloping curve, a visual hallmark of the law of demand.

#### ðŸ“Š Visualizing the Demand Curve

![[Pasted image 20250518203717.png]]

```chartjs
{
  "type": "line",
  "data": {
    "labels": ["0.00", "0.50", "1.00", "1.50", "2.00", "2.50", "3.00"],
    "datasets": [{
      "label": "Quantity Demanded (Ice Cream Cones)",
      "data": [120, 100, 80, 60, 40, 20, 0],
      "borderColor": "#1e88e5",
      "backgroundColor": "rgba(30, 136, 229, 0.2)",
      "fill": false,
      "tension": 0.4
    }]
  },
  "options": {
    "scales": {
      "x": {
        "title": {
          "display": true,
          "text": "Price per Cone (RM)"
        }
      },
      "y": {
        "title": {
          "display": true,
          "text": "Quantity Demanded"
        },
        "beginAtZero": true
      }
    },
    "plugins": {
      "title": {
        "display": true,
        "text": "Demand Curve for Ice Cream Cones"
      }
    }
  }
}
```

The **demand curve** for ice cream cones illustrates how demand decreases as price rises. In healthcare, a similar curve might show fewer patients visiting a clinic as consultation fees increase, highlighting the importance of affordability.

### ðŸ§® Demand Function

Demand is not solely driven by priceâ€”itâ€™s influenced by a range of factors. The **demand function** formalizes this relationship, providing a mathematical framework to analyze how various determinants affect demand.

- **Definition**: *The demand function shows the relationship between quantity demanded and various factors.* It captures the multifaceted nature of demand, beyond just price.
- **Mathematical Form**:
  $$Q_d = f(P, RP, Y, T, \ldots)$$
  - $Q_d$: **Quantity demanded**, the amount consumers want to buy.
  - $P$: **Price of the good**, the primary driver of demand.
  - $RP$: **Prices of related goods**, such as substitutes (e.g., generic drugs) or complements (e.g., syringes for injections).
  - $Y$: **Income**, which affects purchasing power.
  - $T$: **Preferences and tastes of individuals**, such as a growing interest in wellness programs.
- **Implication**: *Demand is multifaceted, influenced by price and non-price factors.* In healthcare, a patientâ€™s decision to seek care depends not only on the cost of a visit but also their income, the price of alternative treatments, and their preference for certain providers.

#### ðŸ©º Demand Function in Healthcare

For example, the demand for flu vaccinations might be expressed as:
- **Price ($P$)**: Lower vaccine costs increase demand.
- **Related goods ($RP$)**: If over-the-counter flu remedies become cheaper, vaccine demand might decrease (substitute effect).
- **Income ($Y$)**: Higher income enables more people to afford vaccinations.
- **Tastes ($T$)**: Public health campaigns promoting vaccination can shift preferences, boosting demand.

### ðŸ”„ Movements vs. Shifts in Demand

Understanding the difference between **movements along** and **shifts of** the demand curve is critical for analyzing how changes in price or other factors affect demand. This distinction is especially relevant in healthcare, where policies like subsidies or income changes can significantly alter utilization.

- **Movements Along the Demand Curve**:
  - *Caused by **changes in the productâ€™s own price**.* A price change leads to a movement along the existing demand curve, reflecting the law of demand.
  - *Example: If ice cream price increases from **RM 1.50 to RM 2.00**, quantity demanded decreases from **60 to 40 cones**.* In healthcare, raising the price of a consultation from RM 20 to RM 30 might reduce visits from 100 to 80 patients.
- **Shifts of the Demand Curve**:
  - *Caused by **changes in non-price determinants**.* These changes shift the entire demand curve, indicating a new level of demand at every price.
  - **Rightward Shift (Increase in Demand)**:
    - *Example: Income doubles (e.g., from RM 5,000 to RM 10,000), increasing demand for ice cream cones.* In healthcare, higher income might lead more people to seek elective procedures like cosmetic surgery.
    - *Graphical Impact: Curve shifts right, indicating higher demand at each price.* The new curve shows more cones demanded at every price level.
  - **Leftward Shift (Decrease in Demand)**:
    - *Example: Price of a related good (e.g., chocolates) drops, reducing ice cream demand.* In healthcare, if generic drugs become cheaper, demand for branded drugs might decrease.
    - *Graphical Impact: Curve shifts left, indicating lower demand at each price.* The new curve shows fewer cones demanded at every price.

#### ðŸ“‰ Healthcare Example of Shifts

A public health campaign promoting mammography could **shift the demand curve right** for breast cancer screenings, as preferences ($T$) change. Conversely, if a cheaper alternative screening method becomes available ($RP$), demand for mammography might **shift left**.

| **Change Type** | **Cause** | **Example** | **Graphical Impact** |
|-----------------|-----------|-------------|----------------------|
| Movement Along Curve | Change in productâ€™s price | Consultation fee rises from RM 20 to RM 30, reducing visits from 100 to 80 | Move along same curve |
| Rightward Shift | Increase in income, preferences, etc. | Income doubles, increasing demand for elective surgeries | New curve to the right |
| Leftward Shift | Drop in price of substitutes, etc. | Cheaper generics reduce demand for branded drugs | New curve to the left |

### ðŸ©º Demand in Healthcare: Empirical Evidence

The principles of demand are vividly illustrated in healthcare through two landmark studies: the **Rand Health Insurance Experiments** and the **Madagascar fee exemption study**. These provide real-world evidence of how price and non-price factors influence healthcare utilization, offering lessons for policy.

#### ðŸ§ª Rand Health Insurance Experiments (1971â€“1982)

The **Rand Health Insurance Experiments** were a groundbreaking study conducted between 1971 and 1982 to explore how **cost-sharing** (e.g., co-pays or deductibles) affects healthcare demand and outcomes.

- **Objective**: *Investigate the effects of **cost-sharing** on:*
  - **Healthcare service utilization** (e.g., doctor visits, hospital admissions).
  - **Appropriateness and quality of care** (e.g., whether care meets medical standards).
  - **Health outcomes** (e.g., patient health status).
- **Methodology**: *Randomized controlled trial (RCT) involving over **2,700 households** in the USA, assigned to insurance plans with varying cost-sharing levels.* Households were randomized into plans ranging from free care to high cost-sharing (up to 95% of costs).
- **Findings**:
  - *Cost-sharing reduced utilization, lowering healthcare costs.* Higher co-pays led to fewer doctor visits and hospital admissions.
  - *No significant impact on the **quality of care** received.* Despite reduced utilization, the care provided remained appropriate.
  - *Health outcomes were generally unaffected by cost-sharing.* For most participants, reduced utilization did not harm health, though vulnerable groups (e.g., low-income) showed some negative effects.
- **Table: Predicted Mean Annual Use of Medical Services by Plan**

| **Plan**              | **Likelihood of Any Use (%)** | **One or More Admissions (%)** | **Medical Expenses (1984 $)** |
|-----------------------|-------------------------------|--------------------------------|-------------------------------|
| Free                  | 86.7 (0.67)                   | 10.37 (0.420)                  | 777 (32.8)                    |
| Family Pay 25%        | 78.8 (0.99)                   | 8.83 (0.379)                   | 630 (29.0)                    |
| Family Pay 50%        | 74.3 (1.86)                   | 8.31 (0.400)                   | 583 (32.6)                    |
| Family Pay 95%        | 68.0 (1.48)                   | 7.75 (0.354)                   | 534 (27.4)                    |
| Individual Deductible | 72.6 (1.14)                   | 9.52 (0.529)                   | 623 (34.6)                    |

  - **Source**: Manning et al. (1987). *Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment*. *The American Economic Review*, 77, 251â€“277.

- **Interpretation**: The data aligns with the **law of demand**â€”higher costs (via cost-sharing) reduced demand for healthcare services. For example, the likelihood of any use dropped from 86.7% (free plan) to 68.0% (95% cost-sharing), and medical expenses fell from $777 to $534. This suggests price is a **key determinant** of healthcare demand, but the lack of impact on quality and outcomes raises questions about balancing cost control with access.

#### ðŸŒ Madagascar Fee Exemption Study (2017)

The **Madagascar fee exemption study** provides compelling evidence of how removing financial barriers can boost healthcare demand, particularly in resource-constrained settings.

- **Context**: *Evaluated the impact of **fee exemptions** for targeted medicines and services in rural Madagascar.* The study focused on rural areas where access to care was limited by point-of-service fees.
- **Findings**:
  - *Before Exemptions: Fewer than **one-third** of people in need accessed healthcare due to point-of-service fees.* High costs deterred utilization, especially for vulnerable groups.
  - *After Exemptions:*
    - ***65% increase** in overall healthcare use.* Removing fees made care more accessible, leading to a surge in demand.
    - ***52% increase** for children under age five.* Young children, a high-risk group, benefited significantly.
    - ***Over 25% increase** in maternity consultations.* Fee exemptions encouraged more women to seek prenatal and postnatal care.
  - *Cost: Sustained at an average direct cost of **US$0.60 per patient**.* The low cost per patient highlights the feasibility of fee exemptions for scaling up access.
- **Implication**: *Removing user fees significantly increases healthcare access, supporting universal health coverage.* This study demonstrates the power of price reductions to shift the demand curve right, particularly for underserved populations.

  - **Source**: Garchitorena et al. (2017). *In Madagascar, Use of Health Care Services Increased When Fees Were Removed: Lessons For Universal Health Coverage*. *Health Affairs*, 36, 1443â€“1451.

- **Interpretation**: The dramatic increase in utilization after fee exemptions reflects the **law of demand**â€”lower prices (or no cost) boost quantity demanded. The focus on children and maternity care underscores the role of **non-price factors** like preferences ($T$) for protecting vulnerable groups, aligning with universal health coverage goals.

### ðŸš€ Policy Implications

These studies highlight the practical relevance of demand dynamics:
- **Cost-Sharing (Rand)**: Policymakers must weigh the benefits of cost control against reduced access, especially for low-income groups where health outcomes may suffer.
- **Fee Exemptions (Madagascar)**: Removing fees can dramatically increase utilization, supporting equity and access in low-resource settings. The low cost (US$0.60/patient) suggests scalability with external support.

---

## ðŸ“ 4. Price Elasticity of Demand (PED)

**Price Elasticity of Demand (PED)** is a powerful tool in **Health Economics**, revealing how sensitive consumers are to price changes for healthcare services, medications, or other goods. This section defines **PED**, explains its calculation, and explores its **interpretation** through practical examples. Weâ€™ll examine different **types of elasticity**, their applications in healthcare and beyond, and real-world **PED estimates** from various countries. Finally, weâ€™ll address the **critical caution** that inelastic demand in healthcare does not imply price increases are harmless, particularly in vulnerable populations. By understanding PED, we can better predict consumer behavior and design equitable healthcare policies.

### ðŸ“‰ What is Price Elasticity?

**Price elasticity of demand (PED) measures the responsiveness of quantity demanded to a change in the price of a good or service.** It quantifies how much demand changes when prices fluctuate, a crucial insight for healthcare pricing strategies and policy design.

- **Definition**: *Price elasticity of demand (PED) measures the responsiveness of quantity demanded to a change in the price of a good or service.* In healthcare, PED helps us understand how a change in the cost of a doctorâ€™s visit or medication affects patient utilization.
- **Purpose**: *Quantifies how sensitive consumers are to price changes.* For example, will a 10% increase in prescription costs significantly reduce demand, or will patients continue purchasing regardless?
- **Formula**:
  $$\text{PED} = \frac{\% \text{ change in quantity demanded}}{\% \text{ change in price}}$$
  This ratio compares the percentage change in quantity demanded to the percentage change in price, yielding a negative value due to the inverse relationship (law of demand).
- **Example**: *If price increases by **10%** and quantity demanded decreases by **20%**:*
  $$\text{PED} = \frac{-20\%}{10\%} = -2$$
  A PED of -2 indicates that demand is highly responsive (elastic) to price changes.

#### ðŸŒ PED in Healthcare

In healthcare, PED is vital for assessing how price changes affect access. For instance, increasing co-pays for clinic visits might deter patients, while subsidizing vaccines could boost uptake. Understanding PED helps policymakers balance cost control with equitable access.

### ðŸ” Interpreting PED

To grasp PEDâ€™s implications, we explore how different **PED values** reflect consumer responsiveness. Using apples as an example, weâ€™ll calculate the impact of price increases on demand, illustrating how PED varies across scenarios.

- **PED = -0.5 (Inelastic)**:
  - *Price increases by **10%**, quantity demanded decreases by **5%**.* A small demand reduction indicates consumers are relatively insensitive to price changes.
  - *Example: Price rises from RM 1.00 to RM 1.10, apple demand falls from 100 to 95.* If apples cost RM 1.00 per unit and rise to RM 1.10 (10% increase), demand drops by 5%, from 100 to 95 apples.
  - *For a **50%** price increase, quantity demanded decreases by **25%**.* A larger price hike (e.g., RM 1.00 to RM 1.50) reduces demand proportionally less, showing inelastic behavior.
- **PED = -1.0 (Unit Elastic)**:
  - *Price increases by **10%**, quantity demanded decreases by **10%**.* The percentage changes are equal, indicating proportional responsiveness.
  - *Example: Price rises from RM 1.00 to RM 1.10, apple demand falls from 100 to 90.* A 10% price increase (RM 1.00 to RM 1.10) leads to a 10% demand drop (100 to 90 apples).
  - *For a **20%** price increase, quantity demanded decreases by **20%**.* A price rise from RM 1.00 to RM 1.20 reduces demand from 100 to 80 apples, maintaining proportionality.
- **PED = -2.0 (Elastic)**:
  - *Price increases by **10%**, quantity demanded decreases by **20%**.* A large demand reduction shows high sensitivity to price changes.
  - *Example: Price rises from RM 1.00 to RM 1.10, apple demand falls from 100 to 80.* A 10% price increase (RM 1.00 to RM 1.10) leads to a 20% demand drop (100 to 80 apples).
  - *For a **20%** price increase, quantity demanded decreases by **40%**.* A price rise from RM 1.00 to RM 1.20 reduces demand from 100 to 60 apples, amplifying the effect.

#### ðŸ©º Healthcare Example

In healthcare, a **PED of -0.5** for clinic visits suggests that a 10% increase in consultation fees (e.g., RM 20 to RM 22) reduces visits by 5%. A **PED of -2.0** for elective procedures indicates that a 10% price hike could deter 20% of patients, reflecting greater sensitivity.

### ðŸ“Š Types of Price Elasticity

PED values categorize demand into **elastic**, **inelastic**, **unit elastic**, **perfectly elastic**, and **perfectly inelastic**, each with distinct implications for pricing and policy. The table below summarizes these types, their characteristics, and examples.

| **Elasticity Type**     | **PED Value** | **Description**                                             | **Examples**                                           |
|-------------------------|---------------|-------------------------------------------------------------|--------------------------------------------------------|
| **Elastic**             | > 1           | *Large change in quantity demanded relative to price change.* Demand is highly sensitive, common for non-essential goods. | Luxury cars, branded goods                             |
| **Inelastic**           | < 1           | *Small change in quantity demanded relative to price change.* Demand is less sensitive, typical for essentials. | Essentials (salt, insulin)                             |
| **Unit Elastic**        | = 1           | *Proportional change in quantity and price.* A 20% price increase reduces demand by 20%. | 20% price increase reduces demand by 20%               |
| **Perfectly Elastic**   | â†’ âˆž           | *Slightest price increase reduces demand to zero.* Common for identical substitutes. | Perfect substitutes (e.g., identical products at RM 5) |
| **Perfectly Inelastic** | = 0           | *Quantity demanded unchanged despite price changes.* Rare, for absolute necessities within affordability. | Life-saving drugs, salt (if affordable)                |

- **Perfectly Elastic Demand Curve**: *Horizontal line at the market price (e.g., RM 5), where elasticity is **infinite**.* If a seller raises the price above RM 5, demand drops to zero due to perfect substitutes.
- **Perfectly Inelastic Demand Curve**: *Vertical line at a fixed quantity, where elasticity is **zero** (rare, e.g., essential medicines within affordability).* Demand remains constant regardless of price, as seen with life-saving drugs like insulin for diabetics, provided costs are affordable.

#### ðŸ©º Healthcare Applications

- **Elastic (PED > 1)**: Elective procedures (e.g., cosmetic surgery) are sensitive to price changes, as patients can delay or forgo them.
- **Inelastic (PED < 1)**: Essential treatments (e.g., dialysis) see minimal demand reduction despite price increases, due to necessity.
- **Perfectly Inelastic (PED = 0)**: Life-saving drugs (e.g., epinephrine for anaphylaxis) may have fixed demand, but only if prices remain within patientsâ€™ means.

### ðŸŒŸ Why Use Elasticity?

PED is a versatile tool for understanding consumer behavior and informing policy, offering a **unit-free measure** that facilitates comparisons across diverse markets.

- **Unit-Free Measure**: *Enables comparison across markets without standardizing units.* Whether measuring apples in kilograms or healthcare visits in appointments, PED allows direct comparisons of responsiveness.
- **Applications**:
  - *Informs **pricing strategies** in healthcare and other sectors.* For example, knowing PED helps hospitals set co-pays that balance revenue and access.
  - *Predicts consumer behavior in response to price changes.* Policymakers can estimate how a new user fee will affect clinic attendance or medication adherence.

#### ðŸš€ Policy Relevance

In healthcare, PED guides decisions like:
- **Subsidies**: Low PED for essential drugs suggests subsidies can maintain access without overuse.
- **User Fees**: High PED for elective services indicates fees can control demand without harming critical care access.
- **Equity**: Understanding PED by income group ensures policies donâ€™t disproportionately burden the poor.

### ðŸŽ Examples of PED

To illustrate PEDâ€™s real-world application, consider the following **demand elasticity estimates** for various goods, highlighting differences in responsiveness.

| **Good or Service** | **Demand Elasticity** |
|---------------------|-----------------------|
| Apples (US)         | 1.15                  |
| Beef (UK)           | 1.45                  |
| Bread (UK)          | 0.26                  |
| Cigarettes (US)     | 0.30â€“0.50             |

- **Source**: Adapted from Folland, Goodman.
- **Interpretation**:
  - **Apples (1.15)** and **Beef (1.45)**: Elastic demand (>1), indicating significant responsiveness to price changes, as these are non-essential or have substitutes.
  - **Bread (0.26)** and **Cigarettes (0.30â€“0.50)**: Inelastic demand (<1), reflecting necessity (bread) or addiction (cigarettes), with minimal demand reduction despite price increases.

### ðŸ©º PED in Healthcare

Healthcare PED varies by country, service type, and population subgroup, as shown in the table below. These estimates highlight the diversity of demand responsiveness and inform targeted policies.

| **Country**   | **Service Type**           | **Overall PED** | **Low Income** | **High Income** | **Source**                      |
|---------------|----------------------------|-----------------|----------------|-----------------|-------------------------------|
| Burkina Faso  | Public Provider (All Ages) | -0.79           | -1.44          | -0.12           | Sauerborn et al. (1994)         |
|               | Age 0â€“1                    | -3.64           |                |                 |                                 |
|               | Age 1â€“14                   | -1.73           |                |                 |                                 |
|               | Age 15+                    | -0.27           |                |                 |                                 |
| CÃ´te d'Ivoire | Health Clinic              |                 | -0.61          | -0.38           | Gertler and van der Gaag (1990) |
|               | Hospital Outpatient        |                 | -0.47          | -0.29           |                                 |
| Ethiopia      |                            | -0.50           |                |                 | Jimenez (1985)                  |
| Ghana         | Hospital Inpatient         | -1.82           |                |                 | Lavy and Quigley (1993)         |
|               | Hospital Outpatient        | -0.25           |                |                 |                                 |
|               | Dispensary                 | -0.34           |                |                 |                                 |
|               | Pharmacy                   | -0.20           |                |                 |                                 |
|               | Health Clinic              | -0.22           |                |                 |                                 |
| Kenya         | Government Provider        | -0.10           |                |                 | Mwabu et al. (1993)             |
|               | Mission Provider           | -1.57           |                |                 |                                 |
|               | Private Provider           | -1.94           |                |                 |                                 |
| Sudan         |                            | -0.37           |                |                 | Jimenez (1986)                  |
| Swaziland     |                            | -0.32           |                |                 | Yoder (1989)                    |

- **Source**: World Health Organization (2003). *Building on the User-fee Experience: The African Case*.
- **Key Observations**:
  - **Burkina Faso**: Overall PED of -0.79 (inelastic), but infants (age 0â€“1) show high elasticity (-3.64), indicating extreme sensitivity to price changes.
  - **Ghana**: Hospital inpatient care (-1.82) is elastic, while outpatient services (-0.25) are highly inelastic, reflecting varying necessity levels.
  - **Kenya**: Government providers (-0.10) are highly inelastic, while private providers (-1.94) are elastic, suggesting patients are more price-sensitive in private settings.
  - **Income Differences**: Low-income groups (e.g., -1.44 in Burkina Faso) are more elastic than high-income groups (-0.12), highlighting equity concerns.

### âš ï¸ Caution: Inelastic Demand in Healthcare

**Inelastic demand (PED < 1) suggests limited responsiveness to price changes, but this does not mean price increases are harmless.** In healthcare, especially in developing countries, price hikes can exacerbate existing barriers to access, with severe consequences for vulnerable populations.

- **Context**: *Inelastic demand (PED < 1) suggests limited responsiveness to price changes, but this does not mean price increases are harmless.* While patients may continue seeking care despite higher costs, the broader impacts on health and equity are significant.
- **Table: Arc Price Elasticities in Burkina Faso (User Fee of US$0.57)**

| **Subgroup**          | **Arc PED** | **% Change in Probability of Seeking Care** |
|-----------------------|-------------|---------------------------------------------|
| Total                 | -0.79       | -5.0%                                       |
| Age <1 year           | -3.64       | -26.0%                                      |
| Age 1â€“14 years        | -1.73       | -12.5%                                      |
| Age 15+ years         | -0.27       | -1.9%                                       |
| Income (1st Quartile) | -1.44       | -10.4%                                      |
| Income (2nd Quartile) | -1.21       | -8.7%                                       |
| Income (3rd Quartile) | -1.39       | -10.0%                                      |
| Income (4th Quartile) | -0.12       | -1.0%                                       |

  - **Source**: Sauerborn et al. (1994). *The Elasticity of Demand for Health Care in Burkina Faso*. *Health Policy and Planning*, 9, 185â€“192.

- **Key Concerns**:
  1. **Underuse in Developing Countries**: *Healthcare is already **seriously underused** (e.g., 0.31 contacts per capita per year in rural Burkina Faso, mostly for serious illnesses). Price increases exacerbate untreated conditions.* With only 0.31 healthcare contacts annually, further reductions due to fees mean serious illnesses go untreated, worsening health outcomes.
  2. **Frivolous Demand**: *Raising prices to curb unnecessary demand is irrelevant in resource-constrained settings where demand is driven by **serious illnesses**.* Unlike in developed countries, where overuse may occur, rural Burkina Fasoâ€™s low utilization reflects genuine need, not frivolous demand.
  3. **Equity Issues**: *Price increases disproportionately affect **children** and **low-income groups**, reinforcing pre-existing inequities in access.* Infants (PED = -3.64) and low-income groups (PED = -1.44) show significant demand drops, limiting their access to care.
  4. **Health Impacts on Children**: *Reduced utilization leads to:*
     - ***Progression of untreated illnesses**.* Children missing care face worsening conditions, increasing morbidity and mortality.
     - ***Missed immunizations**, creating **negative externalities** for the community.* Lower vaccination rates increase disease spread, harming public health.

#### ðŸš€ Policy Implications

The Burkina Faso data underscores the need for caution:
- **Subsidies for Vulnerable Groups**: High PED for infants (-3.64) and low-income groups (-1.44) suggests targeted fee exemptions can significantly boost access.
- **Avoid User Fees**: Inelastic demand overall (-0.79) hides severe impacts on children and the poor, indicating user fees may deepen inequities.
- **Public Health Focus**: Missed immunizations due to reduced utilization highlight the need for free or low-cost preventive care to protect community health.

---

## ðŸ”„ 5. Cross Elasticity of Demand (CED)

**Cross Elasticity of Demand (CED)** is a vital concept in **Health Economics**, illuminating how the price of one good or service influences the demand for another. This section explores **what CED is**, its **calculation**, and how to **interpret** it through examples of substitutes and complements. Weâ€™ll classify goods into **substitute**, **complement**, and **independent** types, and apply CED to healthcare using a **1975 study from Malaysia**. By understanding CED, we can predict how price changes in one healthcare service (e.g., private clinics) affect demand for others (e.g., public clinics), informing policies that enhance access and efficiency.

### ðŸ“ What is Cross Elasticity?

**Cross elasticity of demand (CED) measures the change in quantity demanded of one good in response to a change in the price of another good.** It reveals the interconnectedness of goods in consumer choices, crucial for understanding healthcare markets where patients choose between alternative providers or treatments.

- **Definition**: *Cross elasticity of demand (CED) measures the change in quantity demanded of one good in response to a change in the price of another good.* For example, if the price of private hospital care rises, how does this affect demand for public hospital services?
- **Formula**:
  $$\text{CED}_{AB} = \frac{\% \text{ change in quantity demanded of } A}{\% \text{ change in price of } B}$$
  This ratio compares the percentage change in demand for good A to the percentage change in the price of good B, with the sign (positive, negative, or zero) indicating the relationship between the goods.

#### ðŸŒ CED in Healthcare

In healthcare, CED helps policymakers anticipate how price changes in one service (e.g., branded drugs) affect demand for alternatives (e.g., generics) or related services (e.g., diagnostic tests). This insight is key to designing pricing strategies that promote equitable access and efficient resource use.

### ðŸ” Interpreting CED

To understand CEDâ€™s implications, we explore two examples: **substitutes** (apples and oranges) and **complements** (ink cartridges and printers). These illustrate how CED values reflect the nature of the relationship between goods.

- **Substitutes Example**: Apples (A) and oranges (B).
  - **$CED_{AO} = 0.5$**:
    - *Orange price increases by **10%**, apple demand increases by **5%**.* A rise in orange prices makes apples more attractive, boosting their demand.
    - *Example: Orange price rises from RM 1.00 to RM 1.10, apple demand rises from 100 to 105.* If oranges cost RM 1.00 per unit and increase to RM 1.10 (10% rise), apple demand grows by 5%, from 100 to 105 units.
- **Complements Example**: Ink cartridges (C) and printers (P).
  - **$CED_{CP} = -0.5$**:
    - *Printer price increases by **10%**, cartridge demand decreases by **5%**.* Higher printer prices reduce printer purchases, lowering the need for cartridges.
    - *Example: Printer price rises from RM 1,000 to RM 1,100, cartridge demand falls from 100 to 95.* A 10% price increase for printers (RM 1,000 to RM 1,100) leads to a 5% drop in cartridge demand, from 100 to 95 units.

#### ðŸ©º Healthcare Application

In healthcare, CED explains patient behavior:
- **Substitutes**: If private clinic fees rise, patients may switch to public clinics (positive CED).
- **Complements**: If the cost of dialysis machines increases, demand for dialysis fluid may decrease (negative CED).
These dynamics guide policies like subsidizing public care to offset private price hikes.

### ðŸ›ï¸ Types of Goods

CED classifies goods based on their **relationship**, with the **sign** of the CED value indicating whether goods are **substitutes**, **complements**, or **independent**. The table below summarizes these types, their characteristics, and examples.

| **Type**              | **CED Sign** | **Description**                    | **Examples**                                                                    |
|-----------------------|--------------|------------------------------------|---------------------------------------------------------------------------------|
| **Substitute Goods**  | Positive     | *Goods that can replace each other.* A price increase in one boosts demand for the other. | Apples and oranges, Coke and Sprite, butter and margarine, cakes and chocolates |
| **Complement Goods**  | Negative     | *Goods consumed together.* A price increase in one reduces demand for the other. | Printers and cartridges, shavers and blades, glucose monitors and strips        |
| **Independent Goods** | Near Zero    | *Goods with unrelated consumption.* Price changes in one have minimal impact on the other. | Flowers and radios, shoes and tables, durians and apples                        |

- **Substitutes**: *Goods that can replace each other.* For example, if the price of Coke rises, consumers may buy Sprite instead, resulting in a **positive CED**.
- **Complements**: *Goods consumed together.* A rise in printer prices reduces demand for ink cartridges, yielding a **negative CED**.
- **Independent Goods**: *Goods with unrelated consumption.* A change in the price of flowers has little effect on radio demand, leading to a **CED near zero**.

### ðŸŒŸ Implications for Healthcare

Understanding these relationships helps:
- **Substitutes**: Promote generics as substitutes for expensive branded drugs to increase access.
- **Complements**: Ensure affordability of paired services (e.g., MRI scans and specialist consultations) to maintain utilization.
- **Independent Goods**: Recognize that unrelated services (e.g., dental care and physiotherapy) require separate pricing strategies.

### ðŸ©º CED in Healthcare: Malaysia (1975 Study)

A **1975 study in Malaysia** provides valuable insights into how CED applies to healthcare, highlighting how price changes in one healthcare service affect demand for others. While dated, the findings remain relevant for understanding substitution effects and policy design.

- **Study**: Heller (1982). *A Model of the Demand for Medical and Health Services in Peninsular Malaysia*. *Social Science & Medicine*, 16, 267â€“284.
- **Findings**:
  - **Outpatient Care**: *Highly **inelastic** to cash price (PED = -0.04).* Patientsâ€™ demand for outpatient services is relatively insensitive to price changes, reflecting necessity.
  - **Substitution Effects**:
    - **Public vs. Private Clinics**: *Cross elasticity of demand for public care due to private care price changes is **+0.15**.* A 10% increase in private clinic fees (e.g., RM 50 to RM 55) boosts public clinic demand by 1.5%, indicating substitution.
    - **Traditional vs. Western Care**: *Cross elasticity of demand for traditional care due to western care price changes is **+0.05**.* A 10% rise in western care costs (e.g., RM 100 to RM 110) increases traditional care demand by 0.5%, showing limited substitution.
  - **Additional Insights**:
    - *Consumers are sensitive to **relative prices** of alternative healthcare sources.* Patients weigh the costs of public, private, and traditional care when choosing providers.
    - *Time costs (travel and treatment time) reduce demand for services.* Long travel or waiting times act as non-price barriers, decreasing utilization.
  - **Note**: *Data from 1975; interpret cautiously due to changes in healthcare systems.* Malaysiaâ€™s healthcare landscape has evolved with universal coverage and improved infrastructure, so modern CED values may differ.

#### ðŸš€ Policy Implications

The Malaysia study offers lessons for healthcare policy:
- **Subsidize Public Care**: A **+0.15 CED** for public clinics suggests that keeping public fees low can absorb demand when private costs rise, enhancing access.
- **Promote Western Care**: The **+0.05 CED** for traditional care indicates some patients switch to traditional providers when western care becomes expensive. Ensuring affordable western care can prioritize evidence-based treatments.
- **Reduce Time Costs**: Since *time costs reduce demand*, improving clinic accessibility (e.g., more locations, shorter wait times) can boost utilization.
- **Contextualize Findings**: Given the 1975 data, policymakers should validate these CED estimates with current studies to reflect Malaysiaâ€™s modern healthcare system.

#### ðŸ“Š Summary Table: Malaysia CED Findings

| **Goods Compared**          | **CED Value** | **Interpretation**                                                                 |
|-----------------------------|---------------|-----------------------------------------------------------------------------------|
| Public vs. Private Clinics  | +0.15         | 10% private fee increase â†’ 1.5% public care demand increase (substitutes).         |
| Traditional vs. Western Care | +0.05         | 10% western care price increase â†’ 0.5% traditional care demand increase (substitutes). |
| Outpatient Care (PED)       | -0.04         | Highly inelastic; minimal demand change with price increases.                      |

---

## ðŸ“¦ 6. Dynamics of Supply

**Supply** is a cornerstone of **Health Economics**, offering insights into how healthcare providers, pharmaceutical companies, and other sellers decide how much of a product or service to offer. This section explores the **dynamics of supply** from the **sellerâ€™s perspective**, defining supply, its **key determinants**, and the **law of supply**. Weâ€™ll illustrate these concepts with a **supply schedule for ice cream cones**, introduce the **supply function**, and distinguish between **movements** and **shifts** in the supply curve. By understanding supply, we can analyze how factors like drug production costs or hospital staffing influence healthcare availability, informing policies that ensure adequate service provision.

### ðŸ­ Understanding Supply

**Supply is the amount of a product that sellers are willing and able to sell over a period of time.** In healthcare, this could mean the number of vaccines a manufacturer produces, hospital beds a facility offers, or consultations a clinic provides. Grasping supply dynamics is essential for predicting how providers respond to market conditions.

- **Perspective**: *From the **sellerâ€™s or firmâ€™s viewpoint**.* Supply reflects the decisions of producers, such as hospitals, pharmacies, or medical equipment suppliers, based on their ability and willingness to offer goods or services.
- **Definition**: *Supply is the amount of a product that sellers are willing and able to sell over a period of time.* The term â€œproductâ€ includes both **goods** (e.g., bandages, drugs) and **services** (e.g., surgeries, diagnostic tests).
- **Key Determinants**:
  - **Price** of the product: The **primary factor** driving supply. Higher prices encourage producers to offer more, while lower prices discourage production.
  - **Non-price factors**:
    - **Costs of production**: Expenses like raw materials (e.g., sugar, eggs, milk for ice cream; chemicals for drugs) or labor (e.g., nursesâ€™ salaries) affect supply.
    - **Prices of related goods**: Prices of substitutes or complements in production (e.g., producing generic vs. branded drugs) influence supply decisions.
    - **Technology**: Advances, like automated drug manufacturing, can increase supply.
    - **Preferences**: Producersâ€™ priorities, such as focusing on high-margin specialty drugs, shape supply.

#### ðŸŒ Supply in Healthcare

In healthcare, supply reflects providersâ€™ capacity and incentives. For example, a hospital may increase surgical procedures if fees rise, but high costs for medical equipment or staff shortages could limit supply. Understanding these factors helps policymakers address gaps in healthcare availability.

### ðŸ¦ Supply Schedule for Ice Cream Cones

To illustrate the **law of supply**, consider a **supply schedule for ice cream cones**, which shows how quantity supplied changes with price. This example provides a clear, relatable way to visualize supply principles before applying them to healthcare.

| **Price per Cone (RM)** | **Quantity Supplied** |
|-------------------------|-----------------------|
| 0.50                    | 0                     |
| 1.00                    | 100                   |
| 1.50                    | 200                   |
| 2.00                    | 300                   |
| 2.50                    | 400                   |
| 3.00                    | 500                   |

- **Observation**: *As price increases, quantity supplied increases, reflecting the **law of supply**.* At RM 0.50, no cones are supplied (unprofitable), but at RM 3.00, suppliers offer 500 cones, incentivized by higher revenue.
- **Graphical Representation**: *The **supply curve** slopes **upward**, showing a direct price-quantity relationship.* Plotting the schedule on a graph (price on the y-axis, quantity on the x-axis) produces an upward-sloping curve, a visual hallmark of the law of supply.

#### ðŸ“Š Visualizing the Supply Curve

The **supply curve** for ice cream cones demonstrates how higher prices motivate suppliers to produce more. In healthcare, a similar curve might show a hospital offering more surgeries as procedure fees increase, highlighting the role of price incentives.

### âš–ï¸ Law of Supply

The **law of supply** is a fundamental economic principle, describing the direct relationship between price and quantity supplied. It explains why healthcare providers adjust their offerings based on financial incentives.

- **Statement**: *Other things being equal, when the price of a product rises, the quantity supplied rises, and when the price falls, the quantity supplied falls.* This principle holds in healthcare, where higher reimbursement rates encourage providers to offer more services.
- **Intuition**: *Higher prices incentivize producers to supply more, while lower prices reduce supply incentives.* For example, if consultation fees drop, clinics may reduce operating hours, limiting supply, whereas higher fees could lead to extended hours or more staff.

#### ðŸ©º Healthcare Example

If the government increases payments for vaccinations, manufacturers may boost production, increasing supply. Conversely, low reimbursement rates for certain procedures might lead hospitals to prioritize more profitable services, reducing supply for less lucrative ones.

### ðŸ§® Supply Function

Supply is influenced by more than just priceâ€”it depends on a range of factors. The **supply function** formalizes this relationship, providing a mathematical framework to analyze how various determinants affect supply.

- **Definition**: *The supply function shows the relationship between quantity supplied and various factors.* It captures the multifaceted nature of supply decisions.
- **Mathematical Form**:
  $$Q_s = f(P, RP, C, T, \ldots)$$
  - $Q_s$: **Quantity supplied**, the amount producers offer.
  - $P$: **Price of the good**, the primary driver of supply.
  - $RP$: **Prices of related goods**, such as substitutes or complements in production (e.g., producing surgical tools vs. diagnostic equipment).
  - $C$: **Costs of production**, including raw materials (e.g., milk, sugar, eggs for ice cream; active ingredients for drugs) and labor.
  - $T$: **Technology or preferences**, such as automated manufacturing or a focus on high-demand medical devices.
- **Example**: *A decrease in **production costs** (e.g., price of sugar, eggs, and milk drops by half) shifts the supply curve **right**, increasing supply.* In healthcare, lower costs for vaccine ingredients could lead manufacturers to supply more doses.

#### ðŸ©º Supply Function in Healthcare

For example, the supply of insulin might be expressed as:
- **Price ($P$)**: Higher insulin prices increase supply.
- **Related goods ($RP$)**: If producing diabetes test strips becomes more profitable, insulin production might decrease.
- **Costs ($C$)**: Cheaper raw materials or labor reduce production costs, boosting supply.
- **Technology ($T$)**: Advances in biomanufacturing increase insulin production efficiency, shifting the supply curve right.

### ðŸ”„ Shifts in Supply

Understanding the difference between **movements along** and **shifts of** the supply curve is critical for analyzing how changes in price or other factors affect supply. This distinction is vital in healthcare, where policies like subsidies or technological advancements can significantly alter service availability.

- **Shifts of the Supply Curve**:
  - *Caused by **changes in non-price factors**.* These changes shift the entire supply curve, indicating a new level of supply at every price.
  - **Rightward Shift (Increase in Supply)**:
    - *Example: Lower costs of raw materials (e.g., sugar, eggs, milk) increase ice cream supply.* Cheaper ingredients make production more profitable, encouraging suppliers to offer more cones.
    - *Graphical Impact: Curve shifts right, indicating higher supply at each price.* The new curve shows more cones supplied at every price level.
  - **Leftward Shift (Decrease in Supply)**:
    - *Example: Higher ingredient costs or production disruptions reduce supply.* For instance, a sugar shortage or labor strike could limit ice cream production.
    - *Graphical Impact*: The curve shifts left, indicating lower supply at each price.

#### ðŸ©º Healthcare Example of Shifts

A technological breakthrough in MRI machine production could **shift the supply curve right**, increasing the availability of diagnostic scans. Conversely, a shortage of skilled radiologists might **shift the curve left**, reducing scan availability.

| **Change Type** | **Cause** | **Example** | **Graphical Impact** |
|-----------------|-----------|-------------|----------------------|
| Movement Along Curve | Change in productâ€™s price | Consultation fee rises from RM 20 to RM 30, increasing appointments offered | Move along same curve |
| Rightward Shift | Lower production costs, better technology | Cheaper vaccine ingredients increase supply | New curve to the right |
| Leftward Shift | Higher costs, disruptions | Nurse shortage reduces clinic hours | New curve to the left |

#### ðŸš€ Policy Implications

Supply dynamics inform healthcare policies:
- **Subsidize Production**: Lowering costs (e.g., tax breaks for drug manufacturers) can shift the supply curve right, increasing access to essential medicines.
- **Invest in Technology**: Advances in medical equipment production boost supply, reducing wait times for diagnostics or treatments.
- **Address Shortages**: Tackling non-price factors like staff shortages or supply chain disruptions prevents leftward shifts, ensuring service availability.

---

## ðŸª 7. Understanding Markets

**Markets** are the heart of economic activity, where buyers and sellers interact to determine the allocation of goods and services. In **Health Economics**, understanding markets is crucial for analyzing how healthcare services, medications, and medical equipment are provided and accessed. This section defines **what a market is**, explores the **interactions** between buyers and sellers, outlines the **characteristics** that define markets, and introduces the **types of market structures**, from perfect competition to monopolies. By mastering these concepts, we can better understand healthcare delivery systems and design policies that promote efficiency and equity.

### ðŸ“– What is a Market?

**A market for any good or service consists of all the buyers and sellers of that good or service.** Markets are dynamic arenas where supply meets demand, shaping prices and quantities in healthcare and beyond. Whether itâ€™s patients seeking doctor visits or hospitals offering surgeries, markets determine how resources are distributed.

- **Definition**: *A market for any good or service consists of all the buyers and sellers of that good or service.* In healthcare, this could be the market for generic drugs, where pharmaceutical companies (sellers) and patients or pharmacies (buyers) interact.
- **Interactions**:
  - **Buyers**: *Determine **quantity demanded** based on prices.* Patients decide how many clinic visits or medications to purchase depending on costs and their needs.
  - **Sellers (Firms)**: *Determine **quantity supplied/produced** based on prices.* Hospitals or drug manufacturers adjust their offerings based on the revenue potential of services or products.
  - **Outcome**: *Prices adjust to balance supply and demand.* Market forces drive prices to a level where the quantity buyers want matches what sellers provide, achieving equilibrium.

#### ðŸŒ Markets in Healthcare

Healthcare markets include:
- **Service Markets**: Patients (buyers) and hospitals or clinics (sellers) for consultations, surgeries, or diagnostics.
- **Pharmaceutical Markets**: Patients or healthcare systems (buyers) and drug companies (sellers) for medications.
- **Equipment Markets**: Hospitals (buyers) and medical device manufacturers (sellers) for tools like MRI machines.
Understanding these markets helps policymakers address issues like high drug prices or hospital overcrowding.

### ðŸ” Characteristics of Markets

Markets vary widely, and their structure influences how goods and services are priced and distributed. The **characteristics of markets**â€”number of sellers, product differentiation, and entry/exit barriersâ€”shape competition and efficiency, with significant implications for healthcare.

- **Number of Sellers**: *Ranges from one (monopoly) to many (perfect competition).* A single provider (e.g., a sole hospital in a rural area) operates differently from a market with numerous clinics competing for patients.
- **Product Differentiation**: *Products may be **identical** (e.g., ice cream cones from different vendors) or **differentiated** (e.g., branded ice creams).* In healthcare, generic drugs are nearly identical, while branded drugs or specialized hospitals offer differentiated services.
- **Entry/Exit Barriers**: *Ease or difficulty for new firms to enter or leave the market.* High barriers, like regulatory requirements or costly infrastructure, limit new hospitals, while lower barriers allow more pharmacies to open.

#### ðŸ©º Healthcare Implications

These characteristics affect healthcare markets:
- **Number of Sellers**: A single hospital (monopoly) may charge higher prices, while multiple clinics (competition) drive costs down.
- **Product Differentiation**: Patients may prefer a renowned hospital (differentiated) over a standard clinic, influencing demand.
- **Entry/Exit Barriers**: Strict licensing or high setup costs deter new healthcare providers, potentially limiting access in underserved areas.

### ðŸ“Š Types of Market Structures

Markets are classified into **structures** based on the number of firms, product type, and entry/exit conditions. Each structure has unique implications for pricing, competition, and efficiency. The table below summarizes the **types of market structures**, their characteristics, and examples, providing a framework for analyzing healthcare markets.

| **Structure**                | **Number of Firms** | **Product Type**       | **Entry/Exit**  | **Example**              |
|------------------------------|---------------------|------------------------|-----------------|--------------------------|
| **Perfect Competition**      | Many                | Identical              | Free            | Agricultural markets     |
| **Monopolistic Competition** | Many                | Differentiated         | Relatively Free | Restaurants              |
| **Oligopoly**                | Few                 | Similar/Differentiated | Moderate        | Telecommunications       |
| **Monopoly**                 | One                 | Unique                 | Restricted      | Utility companies        |
| **Monopsony**                | One buyer           | Multiple suppliers     | Varies          | Government as sole buyer |

- **Perfect Competition**: *Many firms, identical products, free entry/exit.* Numerous small providers (e.g., generic drug manufacturers) compete, keeping prices low and aligning production with demand.
- **Monopolistic Competition**: *Many firms, differentiated products, relatively free entry/exit.* Clinics offering unique services (e.g., specialized care) compete on quality or branding, with some pricing power.
- **Oligopoly**: *Few firms, similar or differentiated products, moderate barriers.* A few large hospital chains dominate a region, coordinating or competing on prices and services.
- **Monopoly**: *One firm, unique product, restricted entry.* A single provider (e.g., a patented drug manufacturer) controls the market, often leading to high prices.
- **Monopsony**: *One buyer, multiple suppliers, varying barriers.* A government healthcare system (e.g., Malaysiaâ€™s Ministry of Health) as the sole buyer of certain drugs can negotiate lower prices from multiple suppliers.

#### ðŸ©º Healthcare Market Examples

- **Perfect Competition**: Generic drug markets, where many manufacturers produce identical drugs (e.g., paracetamol), compete on price.
- **Monopolistic Competition**: Private clinics in urban areas, each offering slightly different services or atmospheres, compete for patients.
- **Oligopoly**: A few major pharmaceutical companies dominate the market for specific drug classes (e.g., insulin producers).
- **Monopoly**: A patented drug (e.g., a new cancer therapy) with no substitutes, allowing the manufacturer to set high prices.
- **Monopsony**: A national health service buying medical supplies in bulk, leveraging its sole-buyer status to secure discounts.

#### ðŸš€ Policy Implications

Understanding market structures informs healthcare policies:
- **Promote Competition**: Encouraging more providers (e.g., new clinics) fosters perfect competition, reducing prices and improving access.
- **Regulate Monopolies**: Price controls on patented drugs prevent exploitative pricing in monopoly markets.
- **Leverage Monopsony Power**: Governments can negotiate lower drug prices, benefiting public healthcare systems.
- **Reduce Barriers**: Streamlining licensing or funding new facilities lowers entry barriers, increasing supply in underserved areas.

#### ðŸ“Š Summary Table: Market Structures in Healthcare

| **Structure**                | **Healthcare Example**                     | **Implication**                              |
|------------------------------|--------------------------------------------|----------------------------------------------|
| Perfect Competition          | Generic drug market                        | Low prices, high efficiency                 |
| Monopolistic Competition     | Private clinics with unique services       | Varied prices, competition on quality        |
| Oligopoly                    | Major hospital chains                      | Potential for high prices, limited choices   |
| Monopoly                     | Patented drug manufacturer                 | High prices, need for regulation            |
| Monopsony                    | Government buying medical supplies         | Lower prices through bulk purchasing        |

---

## ðŸŒŸ 8. Perfectly Competitive Market

The **perfectly competitive market** is an idealized model in **Health Economics** that showcases how markets can achieve maximum efficiency. While rare in reality, particularly in complex healthcare systems, understanding perfect competition provides a **benchmark** for evaluating real-world markets and designing policies to enhance access and efficiency. This section outlines the **characteristics** of perfect competition, explains **why itâ€™s worth studying**, and explores the **supply curve** in this context. By mastering these concepts, we can assess how closely healthcare markets align with this ideal and identify ways to improve resource allocation.

### ðŸ“‹ Characteristics

A **perfectly competitive market** is defined by specific traits that ensure no single participant can dominate, leading to fair pricing and efficient production. These characteristics create an environment where competition thrives, benefiting consumers and society.

- **Many Small Firms and Customers**: *No single entity can influence the market price.* With numerous small firms and customers, no individual buyer or seller has the power to set prices, ensuring a level playing field. For example, in a perfectly competitive healthcare market, no single clinic or patient could dictate consultation fees.
- **Identical Products**: *Customers are indifferent to which firm they buy from (e.g., identical ice cream cones).* Products are standardized, so buyers choose based on price alone. In healthcare, this might resemble generic drugs, where all versions (e.g., paracetamol) are chemically identical, making brand irrelevant.
- **Freedom of Entry and Exit**: *No barriers prevent firms from entering or leaving the market.* New firms can easily start operations, and existing ones can exit without significant costs. This ensures competition remains robust, as poor performers are replaced by new entrants. In healthcare, this could mean new pharmacies opening without restrictive licensing.
- **Perfect Information**: *Firms and customers are fully informed about products and prices.* Everyone has complete knowledge of quality, availability, and pricing, enabling informed decisions. In healthcare, this would imply patients knowing all treatment options and costs upfront, a rarity in practice.

#### ðŸ©º Healthcare Context

Perfect competition is uncommon in healthcare due to:
- **Differentiated Services**: Hospitals vary in quality, location, or reputation, unlike identical products.
- **Barriers to Entry**: High costs (e.g., building a hospital) and regulations (e.g., licensing) limit new providers.
- **Imperfect Information**: Patients often lack full knowledge of treatment options or prices.
However, markets like generic drugs or telehealth services can approximate perfect competition, offering lessons for policy.

### â“ Why Study Perfect Competition?

**Under perfect competition, the market mechanism performs best**, making it a critical concept for understanding economic efficiency. While not fully achievable in healthcare, perfect competition serves as an **ideal model** to guide improvements in market performance.

- **Efficiency**: *Under perfect competition, the market mechanism performs best.*
  - **Adam Smith**: *Perfectly competitive firms use **societyâ€™s scarce resources** with **maximum efficiency**.* By producing at the lowest cost and aligning output with demand, firms minimize waste, ensuring resources like hospital beds or vaccines are used optimally.
  - **Friedrich Engels**: *Ensures production aligns with **customer preferences** in variety and quantity.* Competitive firms produce exactly what consumers want, in the right amounts, avoiding overproduction or shortages. In healthcare, this would mean providing the right mix of services (e.g., preventive care vs. surgeries) to meet patient needs.
- **Benchmark**: *Serves as an ideal model for understanding market efficiency, though rare in practice.* Perfect competition provides a standard to compare real-world markets, like healthcare, where monopolies or oligopolies often dominate. By studying it, we identify gaps (e.g., high drug prices due to patents) and propose solutions (e.g., promoting generics).

#### ðŸŒ Relevance to Healthcare

Studying perfect competition highlights:
- **Efficiency Goals**: Policies can encourage competition (e.g., more generic drug producers) to lower costs and improve access.
- **Consumer Benefits**: Competitive markets align services with patient needs, reducing prices and enhancing choice.
- **Policy Benchmark**: Comparing healthcare markets to perfect competition reveals inefficiencies, such as high prices from monopolistic drug companies, guiding reforms.

### ðŸ“ˆ Supply Curve in Perfect Competition

The **supply curve** in a perfectly competitive market reflects the unique role of firms as **price takers**, unable to influence market prices. This section explains the **horizontal supply curve** for individual firms, contrasts it with the **market supply curve**, and explores its implications.

- **Horizontal Supply Curve**:
  - *A firmâ€™s output is so **small** it cannot affect the **market price**.* Each firm is too small to influence the overall market, accepting the prevailing price set by supply and demand.
  - *Firms can sell as much as they want at the **prevailing market price**.* For example, a single ice cream vendor can sell any number of cones at the market price (e.g., RM 2.00) without affecting it.
- **Graphical Representation**:
  - **Market Supply Curve**: *Upward sloping, reflecting total supply.* The market supply curve aggregates all firmsâ€™ supply, showing that higher prices encourage more production across the market.
  - **Firmâ€™s Supply Curve**: *Horizontal at the market price, as firms are **price takers**.* For an individual firm, the supply curve is a flat line at the market price (e.g., RM 2.00), indicating they can sell any quantity at that price but cannot charge more.
- **Implication**: *Firms accept the market price without influence.* In perfect competition, firms have no pricing power, ensuring prices reflect true supply and demand dynamics, leading to efficiency.

#### ðŸ©º Healthcare Example

In a perfectly competitive healthcare market (e.g., generic drug production):
- A single manufacturerâ€™s output (e.g., paracetamol tablets) is too small to affect the market price, so they sell at the prevailing price (e.g., RM 0.10 per tablet).
- The **market supply curve** is upward sloping, as higher prices encourage more firms to produce generics.
- The **firmâ€™s supply curve** is horizontal at RM 0.10, allowing the manufacturer to sell any quantity at that price, ensuring low costs for consumers.

#### ðŸ“Š Summary Table: Perfect Competition in Healthcare

| **Aspect**                  | **Description**                                                                 | **Healthcare Example**                          |
|-----------------------------|--------------------------------------------------------------------------------|-------------------------------------------------|
| Many Small Firms            | No single firm influences price.                                               | Numerous generic drug producers.                |
| Identical Products          | Buyers are indifferent to the seller.                                          | Generic paracetamol from different manufacturers. |
| Free Entry/Exit             | No barriers to market entry or exit.                                           | New pharmacies opening without restrictions.     |
| Perfect Information         | Full knowledge of prices and quality.                                          | Patients know all drug prices and efficacy.      |
| Horizontal Firm Supply Curve | Firms sell at market price as price takers.                                    | Drug producer sells at fixed market price.       |
| Efficiency (Adam Smith)     | Maximizes resource use.                                                        | Optimal allocation of medical resources.        |
| Consumer Alignment (Engels) | Production matches preferences.                                                | Right mix of drugs produced for patient needs.  |

#### ðŸš€ Policy Implications

Perfect competition offers lessons for healthcare:
- **Encourage Competition**: Policies promoting more providers (e.g., generic drug manufacturers, telehealth platforms) mimic perfect competition, lowering prices.
- **Reduce Barriers**: Streamlining regulations or funding new clinics facilitates entry, increasing supply.
- **Enhance Information**: Price transparency tools help patients make informed choices, approximating perfect information.
- **Benchmark Efficiency**: Comparing healthcare markets to perfect competition identifies inefficiencies (e.g., high prices from patented drugs) and guides reforms like price controls or subsidies.

---

## âš–ï¸ 9. Supply and Demand Equilibrium

**Supply and demand equilibrium** is the cornerstone of market dynamics, where the forces of buyers and sellers converge to determine prices and quantities. In **Health Economics**, understanding equilibrium helps us analyze how healthcare services, like hospital beds or medications, are priced and allocated. This section defines **what equilibrium is**, illustrates it with an **example from the ice cream cone market**, and explores how **shifts in supply or demand** affect equilibrium. By mastering these concepts, we can predict how changes in healthcare costs or patient needs influence service availability and inform policies that balance access and efficiency.

### ðŸ“– What is Equilibrium?

**Equilibrium is a situation where the price reaches a level where quantity supplied equals quantity demanded.** Itâ€™s the point where the market â€œclears,â€ with no excess or shortfall, ensuring resources are allocated efficiently. In healthcare, equilibrium determines how many patients receive care at a given price, impacting access and provider revenue.

- **Definition**: *Equilibrium is a situation where the price reaches a level where quantity supplied equals quantity demanded.* This balance ensures that every buyer willing to pay the market price gets the good or service, and every seller willing to accept that price can sell their output.
- **Mathematical Condition**:
  $$Q_d = Q_s$$
  Here, $Q_d$ (quantity demanded) equals $Q_s$ (quantity supplied), representing the equilibrium point where supply meets demand.
- **Outcome**: *No **shortages** or **surpluses** in a competitive market; price stabilizes at the **equilibrium price**.* In a competitive market, prices adjust naturally to eliminate imbalances, ensuring stability. For example, if too many hospital beds are available (surplus), prices fall; if too few are available (shortage), prices rise.

#### ðŸŒ Equilibrium in Healthcare

In healthcare, equilibrium might occur in the market for clinic visits, where the consultation fee balances the number of patients seeking care with the number of appointments providers offer. Disruptions, like a sudden influx of patients or a shortage of doctors, can shift this balance, requiring price adjustments to restore equilibrium.

### ðŸ¦ Equilibrium Example: Ice Cream Cone Market

To illustrate equilibrium, consider the **ice cream cone market**, where we analyze how prices and quantities align based on supply and demand. This example provides a clear, relatable framework before applying equilibrium to healthcare.

- **Equilibrium Analysis**:

| **Price (RM)** | **Quantity Demanded** | **Quantity Supplied** | **Market State** |
|----------------|-----------------------|-----------------------|------------------|
| 2.00           | 300                   | 300                   | Equilibrium      |
| 2.50           | 200                   | 400                   | Surplus (200)    |
| 1.50           | 400                   | 200                   | Shortage (200)   |

- **Scenarios**:
  - **Price = RM 2.50**: *Excess supply (**surplus of 200 cones**) leads to price reduction.* At RM 2.50, suppliers offer 400 cones, but buyers demand only 200, creating a surplus of 200 cones. Sellers lower prices to clear excess inventory, moving toward equilibrium.
  - **Price = RM 1.50**: *Excess demand (**shortage of 200 cones**) leads to price increase.* At RM 1.50, buyers demand 400 cones, but suppliers provide only 200, causing a shortage of 200 cones. Prices rise as buyers compete, pushing the market toward equilibrium.
  - **Price = RM 2.00**: *Market clears with **equilibrium quantity of 300 cones**.* At RM 2.00, quantity demanded (300) equals quantity supplied (300), achieving equilibrium with no shortages or surpluses.

#### ðŸ©º Healthcare Application

In a healthcare context, equilibrium might occur in the market for flu vaccinations:
- At an **equilibrium price** of RM 20, 1,000 patients demand shots, and clinics supply 1,000 shots.
- At RM 30, demand drops to 600, but supply rises to 1,200, creating a **surplus** of 600 shots, prompting clinics to lower prices.
- At RM 10, demand surges to 1,500, but supply falls to 500, causing a **shortage** of 1,000 shots, leading to price increases.
The market stabilizes at RM 20, ensuring all patients seeking shots at that price are served.

### ðŸ”„ Effects of Shifts on Equilibrium

Changes in **non-price factors**, like production costs or consumer income, can shift the supply or demand curves, altering the equilibrium price and quantity. Understanding these shifts is critical for predicting how healthcare markets respond to policy changes or economic trends.

- **Increase in Supply** (rightward shift):
  - *Lower equilibrium price, higher equilibrium quantity.* A rightward shift in the supply curve means more is supplied at every price, reducing prices and increasing quantities.
  - *Example: Cheaper raw materials (e.g., sugar, eggs, milk) increase ice cream supply, shifting the supply curve right.* Lower production costs allow vendors to offer more cones, leading to a new equilibrium with a lower price and higher quantity.
- **Increase in Demand** (rightward shift):
  - *Higher equilibrium price, higher equilibrium quantity.* A rightward shift in the demand curve means more is demanded at every price, raising prices and quantities.
  - *Example: Rising consumer income boosts ice cream demand, shifting the demand curve right.* Wealthier consumers demand more cones, leading to a new equilibrium with a higher price and higher quantity.

#### ðŸ©º Healthcare Examples

- **Supply Shift**: A government subsidy reduces the cost of producing vaccines, shifting the supply curve right. This lowers vaccine prices and increases the number of doses administered, improving public health.
- **Demand Shift**: A public health campaign raises awareness of diabetes screening, shifting the demand curve right. This increases screening prices and the number of tests conducted, enhancing early detection.

#### ðŸ“Š Summary Table: Effects of Shifts on Equilibrium

| **Shift Type**         | **Cause**                          | **Effect on Price** | **Effect on Quantity** | **Healthcare Example**                     |
|------------------------|------------------------------------|---------------------|------------------------|--------------------------------------------|
| Increase in Supply     | Lower production costs             | Decreases           | Increases              | Cheaper vaccine production lowers prices   |
| Increase in Demand     | Higher income or preferences       | Increases           | Increases              | Campaign boosts screening demand           |
| Decrease in Supply     | Higher costs or disruptions        | Increases           | Decreases              | Staff shortage reduces clinic appointments |
| Decrease in Demand     | Lower income or cheaper substitutes| Decreases           | Decreases              | Cheaper generics reduce branded drug use   |

#### ðŸš€ Policy Implications

Equilibrium analysis informs healthcare policies:
- **Subsidies**: Subsidizing production (e.g., cheaper medical supplies) shifts supply right, lowering prices and increasing access to care.
- **Demand Incentives**: Campaigns or income support shift demand right, raising utilization of preventive services but potentially increasing costs.
- **Address Shortages/Surpluses**: Monitoring equilibrium helps avoid shortages (e.g., insufficient hospital beds) or surpluses (e.g., excess drug stockpiles) by adjusting prices or policies.
- **Stabilize Markets**: Policies ensuring price flexibility (e.g., avoiding price caps that cause shortages) maintain equilibrium, balancing access and provider viability.

---

## ðŸ§¾ 10. Recap and Key Principles

This final section of the **HE 2 - Basic Economic Tools** lecture consolidates the core concepts covered, providing a clear and concise **recap** of the essential principles that underpin **Health Economics**. We revisit the **core economic laws** of supply and demand, explore the foundations of **rational decision-making**, and highlight the **key takeaways** that tie these ideas together. These principles form the backbone of economic analysis in healthcare, equipping us to tackle real-world challenges like pricing medications, optimizing hospital resources, and designing equitable health policies. By mastering these concepts, we can apply economic reasoning to improve healthcare delivery and access.

### ðŸ“‹ Core Economic Laws

The **law of demand** and **law of supply** are the foundational pillars of market dynamics, describing how prices influence consumer and producer behavior. These laws are critical for understanding how healthcare markets function, from patient demand for services to provider supply of treatments.

- **Law of Demand**: *When the price falls, the quantity demanded rises.* This inverse relationship means lower prices make goods or services, like clinic visits or medications, more affordable, increasing consumer demand. For example, reducing the cost of a flu shot from RM 30 to RM 15 encourages more patients to get vaccinated.
- **Law of Supply**: *When the price increases, the quantity supplied rises.* Higher prices incentivize producers to offer more, as they earn greater revenue. In healthcare, if consultation fees rise from RM 20 to RM 30, clinics may extend hours or hire more staff to supply additional appointments.

#### ðŸŒ Healthcare Relevance

These laws explain:
- **Demand**: Why subsidized drugs see higher uptake, as lower prices boost patient demand.
- **Supply**: Why hospitals increase surgical capacity when procedure reimbursements rise, reflecting higher supply incentives.

### ðŸ§  Rational Decision-Making

**Rational decision-making** is at the heart of economic behavior, guiding how individuals, patients, and providers make choices under constraints. In healthcare, this framework helps us understand why patients prioritize certain treatments or why providers allocate resources in specific ways.

- **Rational Person**: *Aims to **maximize utility** (satisfaction) within **limited resources**.* Individuals seek the greatest benefit (e.g., health improvement, convenience) given their constraints, such as budget or time. For example, a patient might choose a generic drug over a branded one to maximize health benefits within their financial limits.
- **Decision Process**: *Balances **costs** (including **opportunity costs**) and **benefits**.* Costs include monetary expenses (e.g., treatment fees) and opportunity costs (e.g., time spent at a clinic instead of working). Benefits include health outcomes or peace of mind. A patient weighs the cost of a specialist visit against the benefit of a diagnosis.
- **Marginal Analysis**: *Focuses on **incremental costs and benefits**, foundational for **economic evaluations in healthcare**.* This approach examines the additional cost and benefit of one more unit of a good or service. For instance, in healthcare evaluations, marginal analysis assesses whether the extra cost of a new drug is justified by its additional health benefits, guiding decisions like formulary inclusion.

#### ðŸ©º Healthcare Application

Rational decision-making informs:
- **Patient Choices**: Patients decide whether a costly procedure is worth the health benefit, considering both direct costs and opportunity costs (e.g., lost wages).
- **Provider Decisions**: Hospitals use marginal analysis to determine if adding a new MRI machine justifies the cost with increased diagnostic capacity.
- **Policy Evaluations**: Governments assess whether funding an extra vaccination program yields sufficient health benefits to outweigh its incremental cost.

### ðŸŒŸ Key Takeaways

The lectureâ€™s core conceptsâ€”**demand and supply**, **elasticity**, **perfect competition**, and **equilibrium**â€”form a cohesive framework for analyzing healthcare markets. These **key takeaways** summarize the essential insights, highlighting their practical relevance for policy and decision-making.

- **Demand and Supply**: *Driven by price and non-price factors, visualized through **curves** and **functions**.* Demand reflects patient willingness to seek care, influenced by prices, income, and preferences ($Q_d = f(P, RP, Y, T, \ldots)$). Supply reflects provider offerings, driven by prices, production costs, and technology ($Q_s = f(P, RP, C, T, \ldots)$). Curves and functions help visualize these relationships, guiding healthcare resource allocation.
- **Elasticity**: *Measures responsiveness, critical for pricing and policy in healthcare.* Price elasticity of demand (PED) shows how price changes affect utilization (e.g., PED = -0.79 for healthcare in Burkina Faso), while cross elasticity (CED) reveals substitution effects (e.g., CED = +0.15 for public vs. private clinics in Malaysia). These metrics inform pricing strategies and equity-focused policies.
- **Perfect Competition**: *Ideal market structure for **efficiency**, serving as a benchmark for real-world markets.* With many firms, identical products, free entry/exit, and perfect information, perfect competition maximizes resource efficiency and aligns production with consumer needs. Though rare in healthcare, it guides policies to promote competition (e.g., generic drugs).
- **Equilibrium**: *Balances supply and demand, ensuring no shortages or surpluses.* At equilibrium ($Q_d = Q_s$), prices stabilize (e.g., RM 2.00 for 300 ice cream cones), preventing imbalances. In healthcare, equilibrium ensures patients access care without excessive wait times or unused capacity, guiding policies to maintain market stability.

#### ðŸ“Š Summary Table: Key Principles in Healthcare

| **Concept**            | **Description**                                                                 | **Healthcare Application**                              |
|------------------------|--------------------------------------------------------------------------------|---------------------------------------------------------|
| Law of Demand          | Price falls â†’ quantity demanded rises.                                         | Lower drug prices increase patient uptake.              |
| Law of Supply          | Price rises â†’ quantity supplied rises.                                         | Higher fees encourage more clinic appointments.         |
| Rational Decision-Making | Maximizes utility within constraints, using marginal analysis.                 | Patients choose affordable treatments; providers assess new equipment costs. |
| Demand and Supply      | Driven by price/non-price factors, shown via curves/functions.                 | Predict patient demand and provider supply for services.|
| Elasticity             | Measures responsiveness to price changes.                                      | Guides pricing to balance access and revenue.           |
| Perfect Competition    | Ideal for efficiency, benchmark for markets.                                   | Promotes generic drugs for lower prices.                |
| Equilibrium            | Balances supply and demand, no shortages/surpluses.                            | Ensures stable access to care without delays or waste.  |

#### ðŸš€ Implications for Health Economics

These principles empower us to:
- **Analyze Markets**: Use demand/supply curves and elasticity to predict how price changes affect healthcare utilization (e.g., impact of co-pays on clinic visits).
- **Design Policies**: Apply equilibrium insights to prevent shortages (e.g., vaccine stockouts) or surpluses (e.g., excess hospital beds).
- **Promote Efficiency**: Leverage perfect competition as a goal to reduce costs (e.g., encouraging telehealth competition).
- **Evaluate Decisions**: Use marginal analysis for cost-effectiveness studies, ensuring healthcare investments maximize health benefits.

---

# ðŸ“ Self-Assessment Questions

The following self-assessment questions are designed to test your understanding of the **HE 2 - Basic Economic Tools** lecture, covering **utility measurement**, **supply and demand dynamics**, **price and cross elasticities**, **market structures**, and **equilibrium**. These questions range from foundational concepts to complex applications, encouraging critical thinking and policy analysis in healthcare contexts.

## ðŸ§  Short Answer Questions

These questions test **conceptual understanding** of key economic principles introduced in the lecture, ensuring you grasp definitions and core ideas.

1. **What is utility, and how is it typically measured in economic terms?**
2. **Explain the diamond-water paradox and its implication for pricing in healthcare.**
3. **Define demand and list two non-price determinants that influence it.**
4. **State the law of demand and provide a healthcare example to illustrate it.**
5. **What is the difference between a movement along the demand curve and a shift of the demand curve?**
6. **Define supply and identify one price and one non-price factor affecting it.**
7. **State the law of supply and explain why it applies to healthcare providers.**
8. **What is price elasticity of demand (PED), and why is it a unit-free measure?**
9. **What does a PED of -0.5 indicate about consumer responsiveness, and give a healthcare example?**
10. **Define cross elasticity of demand (CED) and distinguish between substitute and complement goods.**
11. **What is a market, and how do buyers and sellers interact to determine prices?**
12. **List two characteristics of a perfectly competitive market.**
13. **Why is perfect competition considered an efficient market structure, according to Adam Smith?**
14. **Define equilibrium in a competitive market and explain its significance.**
15. **What is marginal analysis, and how is it used in healthcare economic evaluations?**

## ðŸ§® Calculation-based Questions

These questions require **quantitative application** of concepts like **PED**, **CED**, and **equilibrium**, using data from the lecture to test mathematical proficiency and understanding.

1. **Calculating PED for Ice Cream Cones**  
    Using the demand schedule for ice cream cones below, calculate the **PED** when the price increases from RM 1.50 to RM 2.00. Interpret the result.
    
    |**Price per Cone (RM)**|**Quantity Demanded**|
    |---|---|
    |1.50|60|
    |2.00|40|
    
2. **PED for Apples**  
    The lecture notes provide a PED of -0.5 for apples. If the price of apples increases from RM 1.00 to RM 1.10, calculate the percentage change in quantity demanded and the new quantity demanded if the initial quantity is 100 apples.
    
3. **CED for Substitutes**  
    Given a **CED_{AO} = 0.5** for apples (A) and oranges (B), calculate the percentage change in apple demand if the price of oranges increases by 20%. If the initial apple demand is 100 units, what is the new demand?
    
4. **CED for Complements**  
    For ink cartridges (C) and printers (P), the **CED_{CP} = -0.5**. If printer prices rise from RM 1,000 to RM 1,200, calculate the percentage change in cartridge demand and the new quantity demanded if the initial quantity is 100 cartridges.
    
5. **Equilibrium Analysis**  
    Using the ice cream cone market data below, identify the **equilibrium price and quantity**. If the price is set at RM 2.50, calculate the surplus or shortage and explain how the market adjusts.
    
    |**Price (RM)**|**Quantity Demanded**|**Quantity Supplied**|
    |---|---|---|
    |2.00|300|300|
    |2.50|200|400|
    |1.50|400|200|
    

## âœï¸ Short-Essay Questions

These questions require students to **apply concepts** to practical healthcare scenarios, demonstrating **conceptual understanding** and **problem-solving skills**. Each answer should be concise (150â€“200 words) and use lecture concepts.

1. **Applying the Diamond-Water Paradox**  
    Explain how the **diamond-water paradox** applies to healthcare pricing, using an example of an essential drug (e.g., insulin) and a non-essential procedure (e.g., cosmetic surgery). Discuss why prices may not reflect total utility and the implications for healthcare access.
    
2. **Impact of Cost-Sharing**  
    Based on the **Rand Health Insurance Experiments**, discuss how **cost-sharing** affects healthcare utilization. Explain why reduced utilization did not significantly impact quality or health outcomes, and identify potential risks for low-income patients.
    
3. **Fee Exemptions in Madagascar**  
    Using the **Madagascar fee exemption study**, describe how removing user fees influenced healthcare demand. Discuss how this supports **universal health coverage** and suggest one policy lesson for Malaysiaâ€™s healthcare system.
    
4. **Inelastic Demand Risks**  
    The lecture cautions that **inelastic demand** (PED < 1) in healthcare does not mean price increases are harmless. Using Burkina Faso data (e.g., PED = -3.64 for infants), explain why price increases harm vulnerable groups and propose a policy to mitigate this.
    
5. **Substitution in Healthcare**  
    Using the Malaysia (1975) studyâ€™s **CED** findings (e.g., +0.15 for public vs. private clinics), discuss how price changes in private care affect public clinic demand. Suggest a policy to leverage this substitution effect to improve access in Malaysia.
    

## ðŸ©º Structured Case Study Questions

These questions require students to **analyze complex scenarios**, providing **critical analysis** and **policy recommendations**. Each includes **sub-questions** to structure responses, testing **conceptual understanding**, **application**, and **synthesis**.

### Case Study 1: User Fees in Rural Malaysia

**Scenario**: A rural district in Malaysia plans to introduce a user fee of RM 5 for public clinic visits to manage budget constraints. Current utilization is 1,000 visits/month, with a PED of -0.8 overall, -2.0 for children under 5, and -1.5 for low-income households. The goal is to maintain access while covering costs.

- **Sub-questions**:  
    a. Calculate the expected percentage change in clinic visits for each group (overall, children, low-income) after the RM 5 fee (assume a 25% price increase from RM 20).  
    b. Using the **law of demand**, explain why children and low-income groups are more affected.  
    c. Discuss the **equity concerns** raised by the Burkina Faso study (e.g., underuse, health impacts on children).  
    d. Recommend a policy to balance cost recovery and access, using **marginal analysis** to justify your approach.

### Case Study 2: Generic Drug Market in Malaysia

**Scenario**: Malaysia aims to increase access to affordable medications by promoting a **perfectly competitive market** for generic drugs. Currently, patented drugs dominate, with high prices due to monopoly power. Generic producers face barriers like regulatory delays and high setup costs.

- **Sub-questions**:  
    a. Describe the **characteristics** of a perfectly competitive market and how they could apply to generic drugs.  
    b. Explain how a perfectly competitive market could lower prices, referencing **Adam Smith** and **Friedrich Engels**.  
    c. Identify two barriers to entry for generic producers and their impact on **supply**.  
    d. Propose two policies to foster perfect competition, using **supply function** concepts ($Q_s = f(P, RP, C, T, \ldots)$) to explain their impact.

## ðŸ“œ Open-Ended Long Essay Questions

These questions require **in-depth analysis** to address complex healthcare challenges, encouraging **critical thinking**, **synthesis**, and **policy recommendations** with a focus on **Malaysia-specific** and **global applications**. Each answer should be 500â€“800 words, integrating lecture concepts.

1. **Balancing Equity and Efficiency in Malaysiaâ€™s Healthcare System**  
    Using the concepts of **PED**, **CED**, and **equilibrium**, analyze how Malaysia can balance **equity** (access for low-income groups) and **efficiency** (resource allocation) in its public healthcare system. Discuss the **Madagascar fee exemption study** and **Burkina Faso PED data** to draw global lessons. Propose two Malaysia-specific policies (e.g., fee exemptions, subsidies) and one global strategy, justifying them with **marginal analysis** and addressing potential challenges (e.g., budget constraints, provider resistance).
    
2. **Promoting Perfect Competition in Malaysiaâ€™s Pharmaceutical Market**  
    Evaluate the feasibility of achieving a **perfectly competitive market** for pharmaceuticals in Malaysia, considering current monopolistic tendencies (e.g., patented drugs). Use the **characteristics of perfect competition** and **supply curve** concepts to assess barriers (e.g., entry restrictions, information asymmetry). Draw on the **Malaysia 1975 study** (CED = +0.15 for public vs. private care) to discuss substitution effects. Recommend three policies to promote competition, including one global best practice, and explain their impact on **supply**, **demand**, and **equilibrium** prices.
    
3. **Addressing Underuse of Healthcare in Rural Malaysia**  
    Analyze the issue of **underuse** in rural Malaysian healthcare, using **demand function** ($Q_d = f(P, RP, Y, T, \ldots)$) and **Burkina Fasoâ€™s equity concerns** (e.g., 0.31 contacts/year, high PED for infants). Discuss how **price** and **non-price factors** (e.g., income, travel time) contribute to underuse. Propose two Malaysia-specific policies and one global strategy to increase utilization, integrating **CED** insights from Malaysia (1975) and **rational decision-making**. Address potential trade-offs (e.g., cost vs. access) using **marginal analysis**.

---